Mechanical stress and nitric oxide influence leukotriene production in cartilage

Biochemical and Biophysical Research Communications

Volumn 285, Issue 3, 2001, Pages 806-810

  Fermor, Beverley ^a   Haribabu, Bodduluri ^b   Brice Weinberg, J ^c   Pisetsky, David S ^c   Guilak, Farshid ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

^c DURHAM VA MEDICAL CENTER   (United States)

Author keywords

Chondrocyte; Collagen; Cyclooxygenase; Inflammation; Leukotrienes; Lipoxygenase; Mechanical stress; Osteoarthritis; Prostaglandins; Proteoglycan; Rheumatoid arthritis

Indexed keywords

COLLAGEN; LEUKOTRIENE B4; LEUKOTRIENE B4 RECEPTOR; LIPOXYGENASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PROSTAGLANDIN SYNTHASE; PROTEOGLYCAN;

ANIMAL TISSUE; ARTICLE; CARTILAGE; CONTROLLED STUDY; FEMALE; INFLAMMATION; JOINT; MECHANICAL STRESS; MEDIATOR RELEASE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REGULATORY MECHANISM; RHEUMATOID ARTHRITIS; SWINE;

EID: 0034805725     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2001.5237     Document Type: Article

References (30)

1. Cartilage and diathroidial joints as paradigms for hierarchial materials and structures
2. Exercise in the treatment of osteoarthritis
3. Nitric oxide and G proteins mediate the response of bovine articular chondrocytes to fluid-induced shear
4. The effects of static and intermittent compression on nitric oxide production in articular cartilage explants
5. Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthase
6. Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase
7. G-monomethyl-L-arginine
8. Nitric oxide in osteoarthritis
9. Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases
10. Leukotriene B4 plays a critical role in the progression of collagen-induced arthritis
11. Leukotriene B4, a mediator of inflammation present in synovial fluid in rheumatoid arthritis
12. Relationship between leukotriene B4 and immunological parameters in rheumatoid synovial fluid
13. Leukotriene B4, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes
14. Leukotriene B4 stimulates polymorphonuclear leukocyte adhesion to cultured vascular endothelial cells
15. The neutrophil in rheumatoid arthritis
16. Collagen-induced arthritis is reduced in 5-lipoxygenase-activating protein-deficient mice
17. Human mononuclear phagocyte inducible nitric oxide synthase (iNOS). Analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages
18. Chemoattractant receptors activate distinct pathways for chemotaxis and secretion. Role of G-protein usage
19. Arachidonic acid metabolism in polymorphonuclear leukocytes: Unstable intermediate in formation of dihydroxy acids
20. Leukotriene B4 and prostaglandin E2 like activity in synovial fluid in osteoarthritis
21. Effects of recombinant human IL-1 beta on production of prostaglandin E2, leukotriene B4, NAG, and superoxide by human synovial cells and chondrocytes
22. 4 in inflammation
23. The multiplex function of nitric oxide in (auto)immunity
24. Selective inhibition of inducible nitric oxide synthase exacerbates erosive joint disease
25. Nitric oxide synthase inhibitors have opposite effects on acute inflammation depending on their route of administration
26. Regulatory functions of phospholipase A2
27. Mechanically induced calcium waves in articular chondrocytes are inhibited by gadolinium and amiloride
28. Regulation of arachidonic acid release and cytosolic phospholipase A2 activation